Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.36 |
| ▸ | IDH2 | P48735 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CCR2 | P41597 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19690105 | 1.00 | KMT2A (0.39) | KMT2ARAB9AHTTSIGMAR1IDH2 | |
| SCHEMBL19690104 | 1.00 | KMT2A (0.39) | KMT2ARAB9AHTTSIGMAR1IDH2 | |
| SCHEMBL19690283 | 0.84 | PIK3CD (0.45) | KMT2ARAB9AHTTSIGMAR1MEN1 | |
| SCHEMBL19690288 | 0.84 | PIK3CD (0.45) | KMT2ARAB9AHTTSIGMAR1MEN1 | |
| SCHEMBL19690286 | 0.84 | PIK3CD (0.45) | KMT2ARAB9AHTTSIGMAR1MEN1 | |
| SCHEMBL22054752 | 0.81 | RAB9A (0.44) | KMT2ARAB9AHTTSIGMAR1MEN1 | |
| SCHEMBL22054753 | 0.81 | KMT2A (0.39) | KMT2ARAB9AHTTSIGMAR1MEN1 | |
| SCHEMBL19280159 | 0.81 | ORAI1 (0.37) | ALDH1A1 | |
| SCHEMBL19701801 | 0.81 | ORAI1 (0.37) | ALDH1A1 | |
| SCHEMBL22055725 | 0.80 | KMT2A (0.41) | KMT2ARAB9AHTTSIGMAR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3209664-B1 | BICYCLIC HETEROARYL AMINE COMPOUNDS AS PI3K INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2020-06-03 | — | — | EP | disclosed |